First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: A phase II study

被引：0
|
作者：
Djelila Allouache
Sulochana R Gawande
Michele Tubiana-Hulin
Nicole Tubiana-Mathieu
Sophie Piperno-Neumann
Fawzia Mefti
Laurence Bozec
Jean-Yves Genot
机构：
[1] Lion sur mer,Centre F. Baclesse
[2] Lilly Corporate,Eli Lilly and Company
[3] Ctr René Huguenin,undefined
[4] Hopital Dupuytren,undefined
[5] Hospital Curie,undefined
[6] Lilly France,undefined
来源：
BMC Cancer | / 5卷
关键词：
Paclitaxel; Gemcitabine; Metastatic Breast Cancer; Anthracyclines; Inflammatory Breast Cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [11] Phase I/II study of gemcitabine with pegylated liposomal doxorubicin as first-line therapy in Asian women with metastatic breast cancer
    Wong, Zee-Wan
    Ang, Peter Cher-Siang
    Chowbay, Balram
    Wong, Nan-Soon
    See, Hui-Ti
    Khoo, Kei-Siong
    BREAST, 2008, 17 (05) : 517 - 522
  • [12] Weekly docetaxel and gemcitabine as first-line treatment for metastatic breast cancer:: Results of a multicenter phase II study
    Palmeri, S
    Vaglica, M
    Spada, S
    Filippelli, G
    Farris, A
    Palmeri, L
    Massidda, B
    Misino, A
    Ferraù, F
    Comella, G
    Leonardi, V
    Condemi, G
    Mangiameli, A
    De Cataldis, G
    Macaluso, MC
    Cajozzoo, M
    Iannitto, E
    Danova, M
    ONCOLOGY, 2005, 68 (4-6) : 438 - 445
  • [13] First-line paclitaxel and cisplatin used sequentially or in combination in metastatic breast cancer: A phase II randomized study
    Elserafi, Mostafa M.
    Zeeneldin, Ahmed A.
    Abdelsalam, Ibrahim M.
    Nassar, Hanan R.
    Moneer, Manar M.
    Buhoush, Wafa H.
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2018, 30 (01) : 13 - 20
  • [14] Phase II Study of Gemcitabine and Bevacizumab As First-Line Treatment in Taxane-Pretreated, HER2-Negative, Locally Recurrent or Metastatic Breast Cancer
    Borson, Rachel
    Harker, Graydon
    Reeves, James
    Beck, Thaddeus
    Hager, Steven
    Horvath, William
    Jones, Michael
    Tillinghast, Guy
    Arrowsmith, Edward
    Harrer, Grant
    Kudrik, Fred J.
    Malamud, Stephen C.
    Bromund, Jane
    Zeigler, Haoyue
    Tai, Datchen Fritz
    Kornberg, Lori J.
    Obasaju, Coleman
    Orlando, Mauro
    Yardley, Denise A.
    CLINICAL BREAST CANCER, 2012, 12 (05) : 322 - 330
  • [15] Biweekly gemcitabine–paclitaxel, gemcitabine–carboplatin, or gemcitabine–cisplatin as first-line treatment in metastatic breast cancer after anthracycline failure: a phase II randomized selection trial
    Binghe Xu
    Zefei Jiang
    Sung-Bae Kim
    Shiying Yu
    Jifeng Feng
    Artur Malzyner
    Auro del Giglio
    Hyun C. Chung
    Li Jun Shen
    Daniel Lee Kay Pen
    Breast Cancer, 2011, 18 : 203 - 212
  • [16] Gemcitabine plus docetaxel as first-line biweekly therapy in locally advanced and/or metastatic urothelial carcinoma: a phase II study
    Neri, Bruno
    Vannini, Laura
    Giordano, Clara
    Grifoni, Raffaella
    Pantaleo, Pietro
    Baldazzi, Valentina
    Crisci, Alfonso
    Lapini, Alberto
    Raugei, Andrea
    Carini, Marco
    ANTI-CANCER DRUGS, 2007, 18 (10) : 1207 - 1211
  • [17] A phase I-II study of bi-weekly paclitaxel as first-line treatment in metastatic breast cancer
    Gelmon, KA
    Tolcher, A
    O'Reilly, S
    Campbell, C
    Bryce, C
    Shenkier, T
    Ragaz, J
    Ayers, D
    Nakashima, L
    Rielly, S
    Dulude, H
    ANNALS OF ONCOLOGY, 1998, 9 (11) : 1247 - 1249
  • [18] Phase II, multicentre, randomised trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy in patients with HER2-negative metastatic breast cancer
    Park, Yeon Hee
    Im, Seock-Ah
    Kim, Sung-Bae
    Sohn, Joo Hyuk
    Lee, Keun Seok
    Chae, Yee Soo
    Lee, Ki Hyeong
    Kim, Jee Hyun
    Im, Young-Hyuck
    Kim, Ji-Yeon
    Kim, Tae-Yong
    Lee, Kyung-Hun
    Ahn, Jin-Hee
    Kim, Gun Min
    Park, In Hae
    Lee, Soo Jung
    Han, Hye Sook
    Kim, Se Hyun
    Jung, Kyung Hae
    EUROPEAN JOURNAL OF CANCER, 2017, 86 : 385 - 393
  • [19] Combined paclitaxel and gemcitabine as first-line treatment in metastatic non-small cell lung cancer:: a multicentre phase II study
    Douillard, JY
    Lerouge, D
    Monnier, A
    Bennouna, J
    Haller, AM
    Sun, XS
    Assouline, D
    Grau, B
    Rivière, A
    BRITISH JOURNAL OF CANCER, 2001, 84 (09) : 1179 - 1184
  • [20] Combined paclitaxel and gemcitabine as first-line treatment in metastatic non-small cell lung cancer: a multicentre phase II study
    J Y Douillard
    D Lerouge
    A Monnier
    J Bennouna
    A M Haller
    X S Sun
    D Assouline
    B Grau
    A Rivière
    British Journal of Cancer, 2001, 84 : 1179 - 1184
12345